T1	Participants 90 180	Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial
T2	Participants 43 82	depression and impaired quality of life
T3	Participants 859 1081	3400 patients completed the Kansas City Cardiomyopathy Questionnaire, 3395 patients completed European QOL 5D Visual Analog Scale, and 1431 patients in United States and Canada completed the Patient Health Questionnaire-9.
T4	Participants 2010 2234	heart failure with preserved ejection fraction, who were younger had higher New York Heart Association class or comorbid angina pectoris, had lower activity levels, lived in Eastern Europe or were taking hypoglycemic agents,
T5	Participants 2260 2287	impaired QOL and depression
